These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
402 related items for PubMed ID: 28829370
1. MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells. Chung YH, Li SC, Kao YH, Luo HL, Cheng YT, Lin PR, Tai MH, Chiang PH. Int J Mol Sci; 2017 Aug 22; 18(8):. PubMed ID: 28829370 [Abstract] [Full Text] [Related]
2. MicroRNA-145 suppresses cell migration and invasion in upper tract urothelial carcinoma by targeting ARF6. Hsu WC, Li WM, Lee YC, Huang AM, Chang LL, Lin HH, Wu WJ, Li CC, Liang PI, Ke HL. FASEB J; 2020 Apr 22; 34(4):5975-5992. PubMed ID: 32077148 [Abstract] [Full Text] [Related]
3. p53/miR-30a-5p/ SOX4 feedback loop mediates cellular proliferation, apoptosis, and migration of non-small-cell lung cancer. Quan X, Li X, Yin Z, Ren Y, Zhou B. J Cell Physiol; 2019 Dec 22; 234(12):22884-22895. PubMed ID: 31124131 [Abstract] [Full Text] [Related]
4. MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/β-catenin signaling. Chung YH, Cheng YT, Kao YH, Tsai WC, Huang GK, Chen YT, Shen YC, Tai MH, Chiang PH. Sci Rep; 2022 Apr 28; 12(1):6955. PubMed ID: 35484165 [Abstract] [Full Text] [Related]
5. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer. Chang CW, Yu JC, Hsieh YH, Yao CC, Chao JI, Chen PM, Hsieh HY, Hsiung CN, Chu HW, Shen CY, Cheng CW. Oncotarget; 2016 Mar 29; 7(13):16462-78. PubMed ID: 26918943 [Abstract] [Full Text] [Related]
6. Mechanism of Low Expression of miR-30a-5p on Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer. Wang L, Zhao S, Yu M. DNA Cell Biol; 2019 Apr 29; 38(4):341-351. PubMed ID: 30839226 [Abstract] [Full Text] [Related]
7. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway. Li WF, Dai H, Ou Q, Zuo GQ, Liu CA. Tumour Biol; 2016 May 29; 37(5):5885-95. PubMed ID: 26589417 [Abstract] [Full Text] [Related]
8. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer. Zaravinos A, Radojicic J, Lambrou GI, Volanis D, Delakas D, Stathopoulos EN, Spandidos DA. J Urol; 2012 Aug 29; 188(2):615-23. PubMed ID: 22704449 [Abstract] [Full Text] [Related]
9. MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3. Wei W, Yang Y, Cai J, Cui K, Li RX, Wang H, Shang X, Wei D. Cell Physiol Biochem; 2016 Aug 29; 39(3):1165-76. PubMed ID: 27576787 [Abstract] [Full Text] [Related]
10. miR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition by Targeting CDK6 in Nasal Polyps. Zhang T, Zhou Y, You B, You Y, Yan Y, Zhang J, Pei Y, Zhang W, Chen J. Am J Rhinol Allergy; 2021 Mar 29; 35(2):152-163. PubMed ID: 32623901 [Abstract] [Full Text] [Related]
11. MicroRNA-145-5p suppresses cell proliferation, migration, and invasion in upper tract urothelial carcinoma by targeting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase. Luo HL, Lee YC, Chang YL, Hsu WC, Wu YT, Jhan JH, Lin HH, Wu YR, Ke HL, Liu HY. J Cell Biochem; 2023 Sep 29; 124(9):1324-1345. PubMed ID: 37475541 [Abstract] [Full Text] [Related]
12. Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness. Outeiro-Pinho G, Barros-Silva D, Moreira-Silva F, Lobo J, Carneiro I, Morais A, Martins EP, Gonçalves CS, Costa BM, Correia MP, Henrique R, Jerónimo C. Transl Res; 2022 Nov 29; 249():110-127. PubMed ID: 35697274 [Abstract] [Full Text] [Related]
13. Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches. Lee HY, Chen YJ, Li CC, Li WM, Hsu YL, Yeh HC, Ke HL, Huang CN, Li CF, Wu WJ, Kuo PL. Int J Med Sci; 2019 Nov 29; 16(1):93-105. PubMed ID: 30662333 [Abstract] [Full Text] [Related]
14. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY. Breast Cancer Res Treat; 2012 Aug 29; 134(3):1081-93. PubMed ID: 22476851 [Abstract] [Full Text] [Related]
15. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G. Oncol Rep; 2017 Jun 29; 37(6):3543-3553. PubMed ID: 28498428 [Abstract] [Full Text] [Related]
16. The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2. Chen Z, Zhang J, Zhang Z, Feng Z, Wei J, Lu J, Fang Y, Liang Y, Cen J, Pan Y, Huang Y, Zhou F, Chen W, Luo J. Cell Death Dis; 2017 Jun 01; 8(6):e2859. PubMed ID: 28569782 [Abstract] [Full Text] [Related]
17. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie H, Liu Z, Xu Z, Wei J, Huang X, Zheng S. Eur J Surg Oncol; 2014 Nov 01; 40(11):1586-94. PubMed ID: 24290372 [Abstract] [Full Text] [Related]
18. Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma. Izquierdo L, Ingelmo-Torres M, Mallofré C, Lozano JJ, Verhasselt-Crinquette M, Leroy X, Colin P, Comperat E, Roupret M, Alcaraz A, Mengual L. BJU Int; 2014 May 01; 113(5):813-21. PubMed ID: 24180461 [Abstract] [Full Text] [Related]
19. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Kumarswamy R, Mudduluru G, Ceppi P, Muppala S, Kozlowski M, Niklinski J, Papotti M, Allgayer H. Int J Cancer; 2012 May 01; 130(9):2044-53. PubMed ID: 21633953 [Abstract] [Full Text] [Related]
20. miR-30a-5p targets ITGA6 to inhibit oral squamous cell carcinoma progression. Zhang G, Wang H, Liu G, Huang J. Pathol Res Pract; 2024 Jan 01; 253():155021. PubMed ID: 38103366 [Abstract] [Full Text] [Related] Page: [Next] [New Search]